Literature DB >> 18838727

The effect of a quality improvement collaborative to improve antimicrobial prophylaxis in surgical patients: a randomized trial.

Stephen B Kritchevsky1, Barbara I Braun, Andrew J Bush, Michele R Bozikis, Linda Kusek, John P Burke, Edward S Wong, John Jernigan, Cralen C Davis, Bryan Simmons.   

Abstract

BACKGROUND: Quality improvement collaboratives are used to improve health care quality, but their efficacy remains controversial.
OBJECTIVE: To assess the effects of a quality improvement collaborative on preoperative antimicrobial prophylaxis.
DESIGN: Longitudinal cluster randomized trial, with the quality improvement collaborative as the intervention.
SETTING: United States. PARTICIPANTS: 44 acute care hospitals, each of which randomly sampled approximately 100 selected surgical cases (cardiac, hip or knee replacement, and hysterectomy) at both the baseline and remeasurement phases. INTERVENTION: All hospitals received a comparative feedback report. Hospitals randomly assigned to the intervention group (n = 22) participated in a quality improvement collaborative comprising 2 in-person meetings led by experts, monthly teleconferences, and receipt of supplemental materials over 9 months. MEASUREMENTS: Change in the proportion of patients receiving at least 1 antibiotic dose within 60 minutes of surgery (primary outcome) and change in the proportions of patients given any antibiotics, given antibiotics for 24 hours or less, given an appropriate drug, and given a single preoperative dose and receipt of any of the 5 measures (secondary outcome).
RESULTS: The groups did not differ in the change in proportion of patients who received a properly timed antimicrobial prophylaxis dose (-3.8 percentage points [95% CI, -13.9 to 6.2 percentage points]) after adjustment for region, hospital size, and surgery type. Similarly, the groups did not differ in individual measures of antibiotic duration; use of appropriate drug; receipt of a single preoperative dose; or an all-or-none measure combining timing, duration, and selection. LIMITATIONS: Hospitals volunteered for the effort, thereby resulting in selection for participants who were motivated to change. Implementation of the surgical infection prevention measure reporting requirements by the Centers for Medicare & Medicaid Services and The Joint Commission may have motivated improvement in prophylaxis performance.
CONCLUSION: At a time of heightened national attention toward measures of antimicrobial prophylaxis performance, the trial did not demonstrate a benefit of participation in a quality improvement collaborative over performance feedback for improvement of these measures.

Entities:  

Mesh:

Year:  2008        PMID: 18838727     DOI: 10.7326/0003-4819-149-7-200810070-00007

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  13 in total

1.  Selection of hospital antimicrobial prescribing quality indicators: a consensus among German antibiotic stewardship (ABS) networkers.

Authors:  J Thern; K de With; R Strauss; M Steib-Bauert; N Weber; W V Kern
Journal:  Infection       Date:  2013-12-11       Impact factor: 3.553

Review 2.  Interventions to improve antibiotic prescribing practices for hospital inpatients.

Authors:  Peter Davey; Charis A Marwick; Claire L Scott; Esmita Charani; Kirsty McNeil; Erwin Brown; Ian M Gould; Craig R Ramsay; Susan Michie
Journal:  Cochrane Database Syst Rev       Date:  2017-02-09

Review 3.  Understanding the components of quality improvement collaboratives: a systematic literature review.

Authors:  Erum Nadeem; S Serene Olin; Laura Campbell Hill; Kimberly Eaton Hoagwood; Sarah McCue Horwitz
Journal:  Milbank Q       Date:  2013-06       Impact factor: 4.911

4.  Disparities in the regional, hospital and individual levels of antibiotic use in gallstone surgery in Sweden.

Authors:  Gona Jaafar; Bahman Darkahi; Lars Lindhagen; Gunnar Persson; Gabriel Sandblom
Journal:  BMC Surg       Date:  2017-12-06       Impact factor: 2.102

5.  Violation of prophylactic vancomycin administration timing is a potential risk factor for rate of surgical site infections in cardiac surgery patients: a prospective cohort study.

Authors:  Paolo Cotogni; Cristina Barbero; Roberto Passera; Lucina Fossati; Giorgio Olivero; Mauro Rinaldi
Journal:  BMC Cardiovasc Disord       Date:  2017-03-08       Impact factor: 2.298

6.  Nudge strategies to improve healthcare providers' implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within Cochrane systematic reviews.

Authors:  Sze Lin Yoong; Alix Hall; Fiona Stacey; Alice Grady; Rachel Sutherland; Rebecca Wyse; Amy Anderson; Nicole Nathan; Luke Wolfenden
Journal:  Implement Sci       Date:  2020-07-01       Impact factor: 7.327

7.  Impact of pharmacist-led antibiotic stewardship interventions on compliance with surgical antibiotic prophylaxis in obstetric and gynecologic surgeries in Nigeria.

Authors:  Usman Abubakar; Syed Azhar Syed Sulaiman; Adebiyi Gbadebo Adesiyun
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

8.  Systems analysis and improvement to optimize pMTCT (SAIA): a cluster randomized trial.

Authors:  Kenneth Sherr; Sarah Gimbel; Alison Rustagi; Ruth Nduati; Fatima Cuembelo; Carey Farquhar; Judith Wasserheit; Stephen Gloyd
Journal:  Implement Sci       Date:  2014-05-08       Impact factor: 7.327

9.  Use of a national collaborative to improve hospital quality in a low-income setting.

Authors:  Erika Linnander; Zahirah McNatt; Heather Sipsma; Dawit Tatek; Yigeremu Abebe; Abraham Endeshaw; Elizabeth H Bradley
Journal:  Int Health       Date:  2016-01-20       Impact factor: 2.473

10.  Optimizing compliance with surgical antimicrobial prophylaxis guidelines in patients undergoing gastrointestinal surgery at a referral teaching hospital in southern Iran: clinical and economic impact.

Authors:  Laleh Mahmoudi; Mehrdad Ghouchani; Motahareh Mahi-Birjand; Alimohammad Bananzadeh; Ali Akbari
Journal:  Infect Drug Resist       Date:  2019-08-06       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.